Fewer radiation sessions may be just as effective for thymic tumors after surgery
NCT ID NCT07693855
First seen Jul 09, 2026 · Last updated Jul 17, 2026 · Updated 3 times
Summary
This clinical trial is testing a shorter, more intense course of radiation therapy (called hypofractionated radiotherapy) for people who have had surgery for thymic epithelial tumors, including thymoma and thymic carcinoma. The goal is to see if this approach can keep the tumor from coming back in the chest while reducing side effects and protecting heart and lung function. Participants receive either proton or photon radiation over about 3 weeks, with the type chosen by their doctor and them together. The study will track tumor control, side effects, and quality of life for five years.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- Active substance
- Radiation therapy (proton or photon)
- What this could lead to
- If successful, this shorter radiation schedule could become a standard option after thymoma surgery, offering similar tumor control with fewer hospital visits and potentially less long-term toxicity.
- What could go wrong
- This is a single-arm, non-randomized study with only 69 participants, so results may not apply broadly. Radiation still carries risks of heart, lung, or esophageal side effects, and long-term outcomes are not yet known.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for THYMIC CARCINOMA are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
China Medical University Hospital
Taichung, Taiwan
Contact
Contact Phone: •••-•••-•••• Email: •••••@•••••
-
National Taiwan University Cancer Center
Taipei, 106037, Taiwan
Contact
Contact Phone: •••-•••-•••• Email: •••••@•••••
-
National Taiwan University Hospital
Taipei, 100229, Taiwan
Contact
Contact Phone: •••-•••-•••• Email: •••••@•••••
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Shorter radiation after thymic tumor surgery may cut side effects
- Talking therapy shows promise for MG patients with depression in tiny pilot study
- Immune cells engineered to hunt thymus cancer show promise in early trial
- Immunotherapy drug nivolumab tested for rare thymus cancers
- New study aims to uncover hidden clues in myasthenia gravis
- New combo therapy shows promise for rare chest cancer